Boston Trust Walden Corp Corcept Therapeutics Inc Transaction History

Boston Trust Walden Corp

$14 Billion
Q4 2024

A detailed history of Boston Trust Walden Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Boston Trust Walden Corp holds 899,061 shares of CORT stock, worth $61.1 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

899,061

Previous 1,513,975 40.62%

Holding current value

$61.1 Million

Previous $70 Million 35.31%

% of portfolio

0.32%

Previous 0.5%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$44.66 - $60.85 $27.5 Million - $37.4 Million	-614,914 Reduced 40.62%	899,061 $45.3 Million
Q3 2024 Oct 24, 2024	SELL	$29.51 - $46.26 $2.06 Million - $3.23 Million	-69,924 Reduced 4.41%	1,513,975 $70 Million
Q2 2024 Jul 19, 2024	SELL	$22.21 - $34.48 $5.58 Million - $8.66 Million	-251,194 Reduced 13.69%	1,583,899 $51.5 Million
Q1 2024 Apr 22, 2024	SELL	$21.1 - $27.46 $249,634 - $324,879	-11,831 Reduced 0.64%	1,835,093 $46.2 Million
Q4 2023 Jan 24, 2024	BUY	$24.82 - $32.88 $493,347 - $653,555	19,877 Added 1.09%	1,846,924 $60 Million
Q3 2023 Oct 18, 2023	SELL	$21.97 - $33.8 $3.72 Million - $5.72 Million	-169,310 Reduced 8.48%	1,827,047 $49.8 Million
Q2 2023 Jul 24, 2023	BUY	$21.44 - $25.15 $1.65 Million - $1.94 Million	77,178 Added 4.02%	1,996,357 $44.4 Million
Q1 2023 Apr 19, 2023	BUY	$19.2 - $24.47 $1.4 Million - $1.78 Million	72,898 Added 3.95%	1,919,179 $41.6 Million
Q4 2022 Jan 20, 2023	BUY	$19.95 - $29.96 $9.73 Million - $14.6 Million	487,962 Added 35.92%	1,846,281 $0
Q3 2022 Oct 19, 2022	BUY	$24.7 - $29.12 $1.17 Million - $1.38 Million	47,281 Added 3.61%	1,358,319 $34.8 Million
Q2 2022 Jul 22, 2022	BUY	$17.33 - $25.3 $211,876 - $309,317	12,226 Added 0.94%	1,311,038 $31.2 Million
Q1 2022 Apr 20, 2022	BUY	$16.53 - $25.21 $4.43 Million - $6.75 Million	267,805 Added 25.98%	1,298,812 $29.2 Million
Q4 2021 Jan 21, 2022	SELL	$17.1 - $23.34 $527,329 - $719,758	-30,838 Reduced 2.9%	1,031,007 $20.4 Million
Q3 2021 Oct 25, 2021	BUY	$19.68 - $22.53 $6.13 Million - $7.02 Million	311,494 Added 41.51%	1,061,845 $20.9 Million
Q2 2021 Jul 22, 2021	SELL	$19.97 - $24.43 $403,673 - $493,828	-20,214 Reduced 2.62%	750,351 $16.5 Million
Q1 2021 Apr 21, 2021	BUY	$23.49 - $30.56 $8.47 Million - $11 Million	360,721 Added 88.01%	770,565 $18.3 Million
Q4 2020 Jan 15, 2021	BUY	$16.78 - $27.3 $6.88 Million - $11.2 Million	409,844 New	409,844 $10.7 Million

Others Institutions Holding CORT

# of Institutions

361

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Corcept Therapeutics Inc Transaction History